X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-09-16 | NXL | Morad Rick | Dir | P - Purchase | $4.15 | +2,500 | 170,126 | +1% | +$10,375 | |||||
| A | 2022-09-15 | NXL | White Mark | Pres, CEO | P - Purchase | $4.15 | +25,000 | 309,127 | +9% | +$103,750 | |||||
| A | 2022-09-16 | NXL | Kazden Alan | Dir | P - Purchase | $4.15 | +2,500 | 83,131 | +3% | +$10,375 | |||||
2022-09-28 | NXL | Elson Marilyn | Ms. Elson serves as CFO, 10% | P - Purchase | $1.12 | +9,500 | 835,244 | +1% | +$10,640 | ||||||
| A | 2022-09-15 | NXL | White Mark | Pres, CEO | P - Purchase | $4.15 | +25,000 | 289,627 | +9% | +$103,750 | |||||
| D | 2022-09-16 | NXL | Elson Marilyn | Ms. Elson serves as CFO, 10% | P - Purchase | $4.15 | +36,000 | 825,744 | +5% | +$149,400 | |||||
2022-09-16 | NXL | Morad Rick | Dir | P - Purchase | $4.15 | +2,500 | 169,774 | +1% | +$10,375 | ||||||
2022-09-16 | NXL | Kazden Alan | Dir | P - Purchase | $4.15 | +2,500 | 89,131 | +3% | +$10,375 | ||||||
2022-09-16 | NXL | Owens David | Chief Medical Officer | P - Purchase | $4.15 | +2,500 | 141,174 | +2% | +$10,375 | ||||||
2022-09-16 | NXL | White Mark | Pres, CEO | P - Purchase | $4.15 | +2,500 | 289,627 | +1% | +$10,375 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |